Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
Authors
Keywords
-
Journal
Current Rheumatology Reports
Volume 13, Issue 2, Pages 123-131
Publisher
Springer Nature
Online
2011-05-02
DOI
10.1007/s11926-011-0165-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism unde
- (2010) Juan I. Aróstegui et al. ARTHRITIS AND RHEUMATISM
- Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors
- (2010) Madson Q. Almeida et al. HUMAN MOLECULAR GENETICS
- The Role of the Inflammasome in Nonmyeloid Cells
- (2010) Amir S. Yazdi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates
- (2010) Elizabeth Fox et al. JOURNAL OF NEUROIMMUNOLOGY
- Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with Anakinra
- (2010) Loredana Lepore et al. JOURNAL OF PEDIATRICS
- Neurologic manifestations of the cryopyrin-associated periodic syndrome
- (2010) J. L. Kitley et al. NEUROLOGY
- Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1 secretion
- (2010) S. Tassi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How the Noninflammasome NLRs Function in the Innate Immune System
- (2010) J. P. Y. Ting et al. SCIENCE
- Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome
- (2009) Bénédicte Neven et al. ARTHRITIS AND RHEUMATISM
- Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity
- (2009) Susannah D. Brydges et al. IMMUNITY
- A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses
- (2009) Guangxun Meng et al. IMMUNITY
- In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
- (2009) Helen J. Lachmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-inflammatory retinal dystrophy in CINCA syndrome
- (2009) Donato Rigante et al. RHEUMATOLOGY INTERNATIONAL
- A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome
- (2008) Raphaela Goldbach-Mansky et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Superoxide dismutase 1 regulates caspase-1 and endotoxic shock
- (2008) Felix Meissner et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started